Contract Pharma: 'A Modern CDMO' Article
Quotient Sciences' Head of Drug Substance, Paul Quigley, recently shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO in Contract Pharma.
TKS Article: Chemistry 4.0 in pharmaceutical development
Arcinova, a Quotient Sciences business, was featured in an article in TKS magazine: Chemistry 4.0 in pharmaceutical development.
Investigating multi-dimensional problems in drug substance
Arcinova, a Quotient Sciences business, was featured in Chemistry World magazine:"Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise"
Article in Chemicals Knowledge: Continuous transformation of pharmaceutical manufacturing
Arcinova, a Quotient Sciences business, was featured in Chemicals Knowledge Hub: "Continuous transformation of pharmaceutical manufacturing"
Integrated Translational Pharmaceutics® Program conducted in U.S. With DRGT
Quotient Sciences, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration today to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT. This will be Quotient’s first Translational Pharmaceutics program delivered from its U.S. operating facilities.